The introduction of new medicines in the Cuban health system as a response to the medicine shortage in Cuba requires an increase in research and production capacities at IFAL-UH, which must be accompanied by actions that promote the involvement, awareness, training and ownership of the national government entities with competencies in this field.
To this end, the approach used in this Initiative aims to first introduce technologies and methodologies in IFAL-UH, through three specialised internships focused on these methodologies. The first internship will take place at the University of Antwerp, with the aim of studying methodologies and procedures for the development of new plant medicines. The second internship will take place at the University of Namur and will complement the knowledge acquired at the University of Antwerp, with capacity building in pharmaco-toxicological evaluations through laboratory practice. The third internship will take place at the National Polytechnic Institute and will aim to increase and strengthen the knowledge and techniques for obtaining the high quality raw material to be used in producing the new medicines.
The knowledge acquired through the internships will be shared during two separate congresses, one in Mexico and the other in Cuba, which will serve as a meeting point for the scientific and academic community. It will also serve as a platform to create linkages and synergies with official entities, as essential partners in guaranteeing the impact and sustainability of the model to be applied.
In parallel, the Partnership member entities will carry out two study visits, one to IFAL-UH and the other to the IPN, in order to monitor and follow up on training actions and analyse the conditions for introducing the technologies and methodologies that will be transferred to IFAL-UH.
This methodology will allow for constant feedback among all Partnership entities and the joint use of the knowledge generated, thus allowing the provider entities to review and update their methodologies and systems, and to learn from the Cuban experience in the application of its Experimental Pharmacy model.
The Initiative will conclude with a final seminar in Cuba that will bring together all of the professionals involved in the Initiative, as well as national and regional representatives from the government, the public health sector, the pharmaceutical industry, and the scientific and academic communities, where the model for pharmaceutical development will be presented.